925 followers
New article: Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial. https://t.co/dmZV1kDqT4 #CLL #leusm #hematology
New article: Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial. https://t.co/dmZV1kDqT4 #CLL #leusm #hematology